MARSHALL WACE, LLP - ADAMIS PHARMACEUTICALS CORP ownership

ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 30 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q3 2019$31,000
-98.7%
44,380
-88.6%
0.00%
-100.0%
Q1 2016$2,386,000
-9.3%
389,187
-20.1%
0.02%
-8.0%
Q4 2015$2,630,000
+36.7%
487,1040.0%0.02%
+4.2%
Q3 2015$1,924,000
-6.0%
487,1040.0%0.02%
-11.1%
Q2 2015$2,046,000
+6.6%
487,1040.0%0.03%
+8.0%
Q1 2015$1,919,000
+48.1%
487,104
+131.9%
0.02%
+47.1%
Q4 2014$1,296,000
+288.0%
210,014
+194.3%
0.02%
+240.0%
Q3 2014$334,00071,3590.01%
Other shareholders
ADAMIS PHARMACEUTICALS CORP shareholders Q1 2015
NameSharesValueWeighting ↓
Sterling Global Strategies LLC 21,940$71,0000.46%
Leisure Capital Management 157,301$503,0000.43%
BARD ASSOCIATES INC 759,000$2,430,0000.23%
Stonebridge Capital Advisors LLC 32,500$104,0000.02%
LEVEL FOUR ADVISORY SERVICES, LLC 63,500$203,0000.02%
DekaBank Deutsche Girozentrale 700,000$2,240,0000.02%
B. Riley Wealth Advisors, Inc. 21,350$69,0000.01%
Jacobi Capital Management LLC 7,421$24,0000.01%
Patriot Financial Group Insurance Agency, LLC 1,500$5,0000.01%
Cable Hill Partners, LLC 4,000$13,0000.01%
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders